GNGeorgina M. Newbold

Georgina M. Newbold

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Georgina M. Newbold has a total of 56 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Novel Therapy for Severe Bilateral Pyogranulomatous Blepharitis Secondary to Hyaluronic Acid Filler in a Dog

    by Samantha Dacanay‐DeFebo, Andhika Putra, Anne Gemensky‐Metzler, Amanda Davis, Georgina Newbold

    A 9‐year‐old female spayed mixed breed dog was initially examined for severe bilateral entropion secondary to enophthalmos from chronic oral steroid use for immune‐mediated thrombocytopenia as well as potential historic masticatory muscle myositis. Surgical intervention with entropion surgery was pursued; however, trichiasis secondary to laxity of the periocular muscles, eyelid tissues, and tarsal plate developed several months later. Hyaluronic acid (HA) filler (Alayna SG 24 Distinct, BSC Medical Devices GmbH, Munich, Germany) was injected into the superior and inferior eyelids of both eyes to correct recurrent ocular irritation. One month later, the patient developed severe, presumed pyogranulomatous blepharitis in both eyes suspected to be a delayed hypersensitivity reaction to the HA filler. The condition worsened despite medical management. Due to the patient's previous, chronic history of oral steroid use, the owners declined administration of oral steroids at that time. Oral Zenrelia (ilunocitinib) and topical neomycin‐polymyxin‐dexamethasone ointment were instituted, which resulted in a rapid resolution of the patient's clinical signs. This is the first known report of a dog experiencing a severe hypersensitivity reaction to hyaluronic acid used as an eyelid filler and successful treatment with Zenrelia for this purpose.

  • Bilateral Keratouveitis and Secondary Glaucoma in a Young Dog With Immune‐Mediated Polyarthritis and Systemic Inflammatory Response Syndrome

    by Sahana N. Prabhu, Amanda B. Davis, Kelsey R. Brown, Georgina M. Newbold

    A 7‐month‐old intact female mixed‐breed dog presented emergently for inability to walk, lethargy, and vomiting. The patient was diagnosed with immune‐mediated polyarthritis (IMPA) and secondary systemic inflammatory response syndrome (SIRS). Bilateral keratouveitis and secondary glaucoma developed within 24 h of presentation. Thorough diagnostic testing failed to identify an underlying etiology. Despite aggressive medical management, the patient developed rapid vision loss. Due to poor visual prognosis and anticipated need for long‐term medical management, both eyes were enucleated. Histopathological evaluation of both globes revealed severe corneal endothelial injury most consistent with endotheliitis with associated uveitis and endophthalmitis. Testing of ocular tissue with PCR and immunohistochemistry for canine adenovirus was negative, and comprehensive infectious disease screening, joint cultures, and ocular histopathology identified no other causative agents. Following enucleation, the dog systemically improved with anti‐inflammatory and antimicrobial medical management. This report highlights a unique and severe case of bilateral keratouveitis with glaucoma following a systemic inflammatory event.

  • Microbial Surveillance of Commonly Encountered Clinical Surfaces Within a Veterinary Ophthalmology Service

    by Sarah Hoke, Anne Gemensky‐Metzler, Christine Boles, Bailey George, Joany Van Balen Rubio, Dubraska Diaz‐Campos, Georgina Newbold, Dixie Mollenkopf, Thomas Wittum

    Objective: To establish surveillance of organisms found on high‐touch clinical surfaces within a veterinary teaching hospital ophthalmology service and record trends that may foster additional studies investigating links between environmental microbiota and pathogenic bacteria affecting the ocular surface. Procedures: Samples from 17 high touch surfaces in the ophthalmology department of a veterinary teaching hospital were collected over four consecutive Monday mornings, with additional samples taken 9 months later on a Monday morning and Thursday afternoon of the same week. Samples were processed using standard culture methods, with additional specific testing for Salmonella species, carbapenemase‐producing Enterobacteriaceae (CRE), and methicillin‐resistant Staphylococcus (MRSsp). Results: Out of 102 samples collected for aerobic bacterial culture, 11 (11%) showed no growth and 91 (89%) yielded positive results. Of the 211 total isolates found, all exhibited a low colony count. Of the isolates identified, 66/211 (31%) were Staphylococcus spp., followed by 45/211 (21%) Bacillus spp. Exam tables (25/211, 11.8%) and countertops (24/211, 11.4%) had the highest number of isolates. There was no clinically significant difference in the number of isolates found between Monday morning and Thursday afternoon of the same week. Conclusions: All isolates were considered incidental environmental findings and cultured in low numbers. When routine cleaning and disinfection procedures are maintained, common surfaces and equipment of ophthalmology departments are unlikely to be pathogenic reservoirs, posing minimal risk to patients. Further studies are recommended to explore correlations between environmental microbiota and pathogenic bacteria affecting the ocular surface in patients.

  • Retrospective Evaluation of Canine Cutaneous Periocular Idiopathic Histiocytic Disease

    by Samantha J. Dacanay‐DeFebo, Gillian C. Shaw, Kimberley Sebastian, Mika Tamura, Anne Gemensky‐Metzler, Georgina M. Newbold

    Objective: To describe the clinical presentation, management, and histopathologic findings in dogs with cutaneous periocular histiocytic disease. Procedures: Retrospective review of 14 dogs (18 eyes) with cutaneous periocular histiocytic disease from January 2015 to January 2025. Follow‐up data were obtained for 9 dogs (12 eyes). Variables evaluated included age, sex, breed, lesion location, characteristics and duration, histopathologic diagnosis, additional histopathologic staining or further testing performed, treatment, presence of other ocular/periocular disease, and recurrence of the mass after surgery. Results: The most prevalent lesion location was the lower eyelid followed by the lateral canthus. All of the lesions were interpreted as histiocyte‐rich lesions with no identifiable underlying cause. Successful treatment for the 9 dogs (12 eyes) with follow‐up was achieved by surgical excision alone in 2 dogs (2 eyes) and surgical excision with medical management in 7 dogs (10 eyes). Medical management included oral corticosteroids and/or other oral immunosuppressive drugs, subconjunctival corticosteroids, and topical immunomodulatory therapies. Of the nine dogs with follow up, only three dogs experienced lesion recurrence. Following medical management, none of the lesions had recurred in dogs with follow up at the final recheck exam. Conclusion: Histiocytic lesions can affect the periocular tissues and should be included in differential diagnoses for mass lesions around the eyes. Recurrence is uncommon after surgical excision and lesions appear to respond to various immunomodulatory treatments.

  • Open Access

    Retrospective Comparison of Diamond Burr Debridement as a Treatment for Non‐Healing Ulcers Associated With Spontaneous Chronic Corneal Epithelial Defects, Corneal Endothelial Degeneration, and Other Concurrent Ocular Diseases

    by Samantha Dacanay‐DeFebo, Parker Wilcox, Andrew Schroer, Anne Gemensky‐Metzler, Georgina Newbold

    Objective: To determine if superficial corneal ulcers related to corneal endothelial degeneration (CED) or other concurrent ophthalmic disease (COD) had significantly different healing outcomes and incidences of complications post‐diamond burr debridement (DBD) compared to spontaneous chronic corneal epithelial defects (SCCEDs) undergoing DBD. Procedures: Retrospective review of 151 dogs (155 eyes) with non‐healing, superficial corneal ulcers that underwent a DBD. Variables evaluated included age, sex, breed, concurrent diseases, days to healing, complications, and vision status. Group 1 included dogs with true SCCEDs. Group 2 was subdivided into Group 2A and 2B, dogs with CED and COD‐related ulcers, respectively. Results: A single DBD was effective in 88% of SCCEDs, 55% of CED‐associated ulcers, and 72% of COD‐associated ulcers at the first recheck exam at 2 weeks. There was no difference in keratomalacia following the procedure between group 1 and 2A ( p = 0.34) and no cases of keratomalacia occurred in group 2B. Additional procedures were required in 12% of SCCEDs, 44% of CED‐associated ulcers, and 28% of COD‐associated ulceration to facilitate healing. Conclusion: A single DBD is an effective treatment for SCCEDs and can be effective for CED and COD associated ulcers; however, CED and COD associated ulcers are more likely to require repeated DBD or additional procedures to facilitate healing.

  • Open Access

    Ocular examinations before and after total ear canal ablation and bulla osteotomy can help recognize and prevent potential vision-threatening abnormalities in cats and dogs

    by Bianca J. Hartrum, Terah E. R. Webb, Georgina M. Newbold, Anne J. Gemensky-Metzler, Shawn C. Kennedy, Brittney A. Carson

    OBJECTIVE: To report ocular examination findings before and after total ear canal ablation and lateral bulla osteotomy (TECALBO) and ventral bulla osteotomy (VBO) in cats and dogs. METHODS: At The Ohio State University and MedVet Columbus, ophthalmic examinations were performed on client-owned animals for which a TECALBO or VBO was indicated. Examination findings and postoperative complications relating to ophthalmic and/or neuro-ophthalmic diseases were recorded prior to surgery (T0) and at 1 day (T1), 2 to 3 weeks (T14), and ± 2 months (T60) postoperatively. RESULTS: 28 dogs and 22 cats underwent 43 TECALBO and 20 VBO surgeries (63 ears). Reasons for surgery included otitis (52.4%), polyps (30.1%), and aural masses (17.5%). Facial nerve deficits were observed preoperatively in 5.7% of surgeries and postoperatively in 47.2% at T1 and 31.3% at T14. Horner syndrome was present preoperatively in 11.3% and postoperatively in 45.3% at T1 and 37.5% at T14. Keratoconjunctivitis sicca and corneal ulcers were noted, respectively, in 5.7% and 3.8% of cases at T0 and 5.7% and 17% at T1. Facial nerve deficits and Horner syndrome remained present in 29% (5 of 17) and 36% (5 of 14) at T60. One dog with preoperative facial nerve paralysis and Horner syndrome developed a descemetocele that required a conjunctival flap at T14. Overall, 64.2% of surgeries led to ocular and/or neuro-ophthalmic changes postoperatively. CONCLUSIONS: Cats and dogs undergoing TECALBO and VBO procedures should have thorough ophthalmic examinations preoperatively and postoperatively, as ocular and neuro-ophthalmic abnormalities are common in these patients. CLINICAL RELEVANCE: Ocular examinations are important in animals undergoing aural surgeries in order to reveal ocular abnormalities that could require follow-up care or lead to vision-threatening conditions.


  • Open Access

    Periocular fibrosarcoma with lipogranulomatous conjunctivitis in a cat

    by T. M. Foster, G. M. Newbold, E. J. Miller, Y. J. Jeong, C. Premanandan, B. D. Husbands

    A 9‐year‐old, female spayed domestic short‐haired cat was presented with a 4‐year history of bilateral lipogranulomatous conjunctivitis (LGC), which was confirmed via histopathology. Thirteen months following the initial biopsy, the cat was presented with a rapidly progressive mass lesion of the palpebral conjunctiva of the right eye. A surgical debulking, followed 1 month later by exenteration after marked regrowth of the mass confirmed fibrosarcoma. This case report is the first to describe a cat with chronic bilateral LGC that later developed a unilateral fibrosarcoma within the eyelid tissue of the right eye. Fibrosarcoma should be considered a differential in any cat with chronic LGC that develops a rapidly progressive mass in the eyelid.

  • Open Access

    Efficacy of the topical antihistamine olopatadine in dogs with experimentally induced allergic conjunctivitis

    by Esther T. Mamo, Georgina M. Newbold, Shelby C. Moorehead

    Objective: The objective of the study was to evaluate the efficacy of a once a day, over the counter antihistamine eye drop, 0.7% olopatadine hydrochloride, in treating or preventing experimentally induced allergic conjunctivitis in dogs.Animals studied: Twelve systemically healthy pet dogs with no known history of allergies or atopic dermatitis, and in the past 12 months had no known ocular abnormalities.Procedures: Dogs were randomly assigned to two groups: “Treatment” which received topical 0.7% olopatadine hydrochloride and “Control” which received artificial tears. Dogs received the antihistamine eye drops before (Phase 1) or after (Phase 2) receiving a compounded ophthalmic histamine solution to induce clinical signs of allergic conjunctivitis. Conjunctival hyperemia, chemosis, follicles, ocular discharge, and ocular pruritus were graded, and photographs were used to document changes. Schirmer tear test values, fluorescein staining, and intraocular pressures were monitored throughout.Results: In both Phase 1 and Phase 2, conjunctival scores increased 10 min after histamine administration (p < .05). There was no difference between maximum overall conjunctival scores between treatment and control groups in either phase or when comparing treatment groups of Phase 1 to Phase 2 (p > .05). However, treatment groups in Phase 2 did have a higher maximum conjunctival chemosis score and spent more time at their maximum chemosis score when compared to Phase 1 (p < .05).Conclusion: Olopatadine may be beneficial as prophylaxis to reduce the degree and duration of clinical signs of allergic conjunctivitis.


  • Evaluation of a commercial NGS service for detection of bacterial and fungal pathogens in infectious ulcerative keratitis

    by Ashley Bendlin, Anne J. Gemensky‐Metzler, Dubraska Diaz‐Campos, Georgina M. Newbold, Eric J. Miller, Heather L. Chandler

    ObjectivesTo compare results from a commercial next-generation sequencing (NGS) service to corneal cytology and culture for identification of causative organisms in veterinary patients presenting for infectious ulcerative keratitis (IUK). ProcedureSwabs for corneal aerobic and fungal cultures and DNA swabs for NGS were submitted for canine and equine normal controls (n = 11 and n = 4, respectively) and IUK patients (n = 22 and n = 8, respectively) for which microbrush cytology specimens confirmed the presence of infectious organisms. The sensitivity of the NGS results was compared with bacterial and fungal culture results. Concordance between the NGS and culture results was determined. ResultsThe NGS results were positive for bacterial and fungal organisms in 5 and 1 normal and 18 and 1 IUK cases, respectively. Bacterial and fungal cultures were positive for 7 and 2 normal and 20 and 5 IUK cases, respectively. Sensitivity of NGS was 82.14% (95% confidence interval (CI), 63.11% to 93.94%) and specificity was 76.47% (95% CI, 50.10% to 93.19%). Concordance (complete and partial) between identified bacterial and fungal organisms was found in 79% and 100% of cases, respectively. NGS identified organisms in 3 culture-negative IUK samples. ConclusionA commercial NGS service may be useful in the identification of causative agents in IUK cases with a sensitivity greater than the sensitivity previously reported for aerobic culture. Further testing is needed to determine the clinical significance of additional organisms isolated by NGS from infected cases, as well as organisms isolated from normal corneas.


  • Canine endotheliitis: Clinical characteristics, advanced imaging features, and treatment

    by Melaney A. Mayes, Maria Isabel Casanova, Sangwan Park, Kirsten Steele, Lana Linton, Soohyun Kim, Kathryn L. Good, Bret A. Moore, Georgina M. Newbold, Brian C. Leonard, et al.

    Objective: To describe the clinical findings, multimodal corneal imaging features and treatment in canine patients diagnosed with endotheliitis.Animals studied: Four canine patients met inclusion criteria for bilateral corneal disease with endothelial inflammation and secondary corneal edema that responded to topical anti‐inflammatory treatment.Methods: The patients selected underwent a complete ophthalmic examination with emphasis on the cornea including ultrasound pachymetry (USP), Fourier‐domain optical coherence tomography (FD‐OCT), in vivo confocal microscopy (IVCM), and digital slit lamp photography.Results: All patients in this study demonstrated thickened corneas due to edema with USP and FD‐OCT. With IVCM, mild to severe polymegathism and pleomorphism of corneal endothelial cells, reduced endothelial cell density, hyperreflective keratic precipitates (KPs), and extracellular debris as well as hyporeflective pseudoguttata were observed. With FD‐OCT, hyperreflective KPs were commonly observed on the inferior cornea. Clinical examination and advanced imaging results were consistent with a diagnosis of endotheliitis. All patients initially responded to topical anti‐inflammatory treatment and required continued therapy; two patients also received topical netarsudil, a rho‐associated coiled‐coil kinase inhibitor.Conclusion: Endotheliitis should be considered for canine patients with bilateral edema that is most severe in the inferior cornea. Careful inspection of Descemet's membrane–endothelial complex should be performed for KPs or inflammatory debris. Chronic administration of topical anti‐inflammatories may be necessary to prevent flare‐ups of endotheliitis.